Sign in

NCT07853001Not yet recruiting

Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney Resection

A Prospective Cohort Study With Emphasis on Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney Resection - the RAPTOR Study

Source: ClinicalTrials.gov · Last updated 1 Oct 2026

Brief summary (registry, in English)

The target population for this study consists of all patients undergoing kidney surgery at Haukeland University Hospital, Norway, with the primary focus being patients undergoing robot-assisted partial nephrectomy. The study has two main objectives. First, the investigators aim to assess whether a flank approach to robot assisted partial nephrectomy may be superior to a trans abdominal approach with regard to postoperative pain, recovery, and quality of life. Second, while conducting this study, the investigators also seek to compare two methods of renal artery clamping during the partial nephrectomy procedure. Specifically, the investigators aim to determine whether a technique that reduces the duration of ischemia can be performed without causing an unacceptable increase in blood loss or postoperative complications.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
130 (estimated)
First submitted
16 Jun 2026
Start date
Sept 2026
Primary completion date
Sept 2030
Lead sponsor
Bjarte Almas
NCT number
NCT07853001

What you commit to

  • Study type: Interventional
  • Planned participants: 130
  • From Sept 2026 to the primary completion date, Sept 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous kidney surgery on the affected side

Other illness

  • Preexisting severe pain condition requiring regular use of opioids adding up to more than equivalent of 10mg po morphine daily
  • Any other physical or mental illness that according to the treating surgeon makes the patient unfit for inclusion in the study
  • Confirmed metastatic renal cancer or any other metastatic cancer.

Other

  • Preexisting extensive intraabdominal adhesions preventing the use of the transabdominal access

Who the study is looking for

  • Signed written informed consent obtained prior to any study specific procedures
  • Patient must be willing and able to comply with the protocol
  • Age \>18
  • Patients scheduled for robot-assisted partial kidney resection with either the trans- or retroperitoneal access
  • Other patients scheduled for surgery for kidney cancer, to be included as control group

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Haukeland University Hospital
Coordinator of this site? Confirm its status
BergenNorwayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.